Veracyte, Inc. (VCYT)

Last Three Months

21-Jan-24 -- 20-Apr-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment: Reduce

Insider Trading Sentiment: Sell

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

33

0

6

+1

0

+2

0

+3

Two Year Chart

21-Apr-22 -- 20-Apr-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
05-Mar-24 5:28 PM View:	01-Mar-24 Option Sale ($243.60K)	Jones Evan/ Fa Director		Veracyte, Inc. - VCYT	0% 72.77K	0	0	--	--	Show Txns Hide Txns

02-Apr-24 4:17 PM View:	01-Apr-24 Planned Option Sale ($216.53K)	Eastham Karin Director		Veracyte, Inc. - VCYT	0% 33.13K	0	0	--	--	Show Txns Hide Txns

19-Mar-24 4:50 PM View:	15-Mar-24 Payment of Exercise ($46.19K)	Chambers Rebecca Chief Financial Officer		Veracyte, Inc. - VCYT	62% 90.83K to 146.7K	0	0	--	--	Show Txns Hide Txns

08-Mar-24 4:37 PM View:	06-Mar-24 Grant 0	McGuire Annie SVP, General Counsel		Veracyte, Inc. - VCYT	88% 51.79K to 97.33K	0	0	--	--	Show Txns Hide Txns

08-Mar-24 4:36 PM View:	06-Mar-24 Grant 0	Wygant Jonathan VP, Chief Accounting Officer		Veracyte, Inc. - VCYT	79% 27.45K to 49.06K	0	0	--	--	Show Txns Hide Txns

19-Mar-24 4:49 PM View:	15-Mar-24 Payment of Exercise ($125.99K)	Stapley Marc Chief Executive Officer Director		Veracyte, Inc. - VCYT	48% 222.49K to 329.74K	0	0	--	--	Show Txns Hide Txns

08-Mar-24 4:37 PM View:	06-Mar-24 Grant 0	Leite John Chief Commercial Officer-CLIA		Veracyte, Inc. - VCYT	121% 38.69K to 85.56K	0	0	--	--	Show Txns Hide Txns

08-Mar-24 4:36 PM View:	06-Mar-24 Grant 0	Febbo Phillip G. Chief Scientific & Med Officer		Veracyte, Inc. - VCYT	75% 53.18K to 93.09K	0	0	--	--	Show Txns Hide Txns